EFORT Intelligent Equipment (688165.SH) shareholder Xinwei Jishi and its concerted parties plan to reduce their shareholding by no more than 3%.
EFORT Intelligent Equipment (688165.SH) announced that, due to its own funding needs, Xinwei Jishi, a shareholder holding more than 5% of the company, and its concerted party Ma'anshan Jishi plan to reduce their holdings through centralized bidding and block trades by a total of no more than 15.6534 million shares, representing no more than 3% of the company's total share capital.
EFORT Intelligent Equipment (688165.SH) announced that, due to its own funding needs, Xinwei Jishi, a shareholder holding more than 5% of the company, and its concerted party Ma'anshan Jishi plan to reduce their shareholding by a total of no more than 15.6534 million shares through centralized bidding and block trades, with the reduction ratio not exceeding 3% of the company's total share capital.
Related Articles
Primarius Technologies (688206.SH) shareholders plan to reduce their holdings by no more than 2% in total.
General Manager Cheng Zhenghui of APT Medical Inc. (688617.SH) plans to reduce his shareholding by no more than 1.5%.
Shanghai Shen Lian Biomedical Corporation (688098.SH): Phase II clinical trial of UB-221 for the treatment of chronic spontaneous urticaria meets primary endpoint
Primarius Technologies (688206.SH) shareholders plan to reduce their holdings by no more than 2% in total.
General Manager Cheng Zhenghui of APT Medical Inc. (688617.SH) plans to reduce his shareholding by no more than 1.5%.
Shanghai Shen Lian Biomedical Corporation (688098.SH): Phase II clinical trial of UB-221 for the treatment of chronic spontaneous urticaria meets primary endpoint
RECOMMEND
